Latest Breaking News On - Prnewswire milestone pharmaceuticals inc - Page 5 : comparemela.com

Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT

Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJames ipJoseph olivetoMilestone pharmaceuticals incUs securities exchange commissionCompany on twitter at milestonepharmaHeart rhythm societyDivision of cardiologyPrnewswire milestone pharmaceuticals incExchange commissionMilestone pharmaceuticalsHeart rhythmNasal spray is effectiveRepeated spontaneous episodesResults from

Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT

/PRNewswire/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative.

United statesSan franciscoJames ipDavid pittsJoseph olivetoMilestone pharmaceuticals incUs securities exchange commissionCompany on twitter at milestonepharmaHeart rhythm societyDivision of cardiologyPrnewswire milestone pharmaceuticals incExchange commissionMilestone pharmaceuticalsHeart rhythmNasal spray is effectiveRepeated spontaneous episodes

Milestone Pharmaceuticals to Host Virtual Key Opinion Leader Event on Etripamil for the Treatment of PSVT

/PRNewswire/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative.

United statesDavid pittsBruce stamblerSean pokorneyMilestone pharmaceuticals incUs securities exchange commissionDuke university school of medicineCompany on twitter at milestonepharmaArrhythmia researchPiedmont heart instituteDuke clinical research instituteArrhythmia core laboratoryPrnewswire milestone pharmaceuticals incExchange commissionMilestone pharmaceuticalsCardiac electrophysiology key opinion leaders

Milestone Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Update

Milestone Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Update
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesJi xingDavid pittsJoseph olivetoMilestone pharmaceuticals incMontreal heart instituteCenters for diseaseCompany on twitter at milestonepharmaJi xing pharmaceuticalsDrug administrationPrnewswire milestone pharmaceuticals incExchange commissionMilestone pharmaceuticalsChief executive officerExclusive license agreementCommercialize etripamil

Milestone Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Update

Milestone Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJi xingJoseph olivetoDavid pittsargotMilestone pharmaceuticals incMontreal heart instituteCenters for diseaseCompany on twitter at milestonepharmaJi xing pharmaceuticalsDrug administrationPrnewswire milestone pharmaceuticals incExchange commissionMilestone pharmaceuticalsChief executive officerExclusive license agreementCommercialize etripamil